Transdermal Skin Patches Global Market Report 2025

Description

Transdermal skin patches represent a drug delivery method wherein a predetermined dose of medication is administered through an adhesive patch, absorbing into the bloodstream via the skin. These patches offer a precise and predetermined dosage of medication, facilitating absorption through the skin into the bloodstream.

The primary categories within the transdermal skin patches market include fentanyl transdermal patches, nicotine transdermal patches, buprenorphine transdermal patches, clonidine transdermal patches, oxybutynin transdermal patches, and others. Nicotine transdermal skin patches are designed to aid individuals in quitting smoking by providing a controlled source of nicotine through the skin, helping alleviate withdrawal symptoms associated with smoking cessation. Various products in this market utilize matrix, drugs in the adhesive, reservoir, and vapor technologies, catering to applications such as pain relief, nicotine cessation, hormone replacement therapy, as well as addressing neurological and cardiovascular disorders, among others.

The transdermal skin patches market research report is one of a series of new reports from The Business Research Company that provides transdermal skin patches market statistics, including transdermal skin patches industry global market size, regional shares, competitors with a transdermal skin patches market share, detailed transdermal skin patches market segments, market trends and opportunities, and any further data you may need to thrive in the transdermal skin patches industry. This transdermal skin patches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transdermal skin patches market size has grown steadily in recent years. It will grow from $7.46 billion in 2024 to $7.72 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, strong economic growth in emerging markets, the increase in pharmaceutical r&d expenditure and increased healthcare expenditure.

The transdermal skin patches market size is expected to see steady growth in the next few years. It will grow to $9.36 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to the increase in smoking cessation, the rapid growth in the aging population, the increasing healthcare expenditure and the increase in cardiovascular diseases. Major trends in the forecast period include technological advancement in transdermal skin patches, advancements in diabetes transdermal patches, robust research and development activities, product innovation, collaborations and partnerships, wearable skin patches, advancements in microneedle patches for vaccination and new iontophoresis patches.

The rising incidence of cardiovascular disease is anticipated to drive the growth of the transdermal skin patches market in the future. Cardiovascular diseases affect the heart and blood vessels and are often associated with the buildup of fatty deposits in the arteries (atherosclerosis) and an increased risk of blood clots. Transdermal skin patches are utilized to prevent angina (chest pain) in individuals with coronary artery disease, characterized by narrowed blood vessels supplying the heart. They also enhance bioavailability in the treatment of heart failure. For instance, in August 2022, a report from the American College of Cardiology, a U.S.-based non-profit medical association, projected that all four cardiovascular risk factors in the United States would rise between 2025 and 2060. The most significant increase is expected in diabetes, with a 39.3% rise to 55 million individuals, followed by dyslipidemia (up 27.6% to 126 million), hypertension (up 25.1% to 162 million), and obesity (up 18.3% to 126 million). The research also indicated that the most substantial projected increases in cardiovascular disease rates would be for stroke (up 33.8% to 15 million) and heart failure (up 33.4% to 13 million), along with ischemic heart disease (up 30.7% to 29 million) and heart attack (up 16.9% to 16 million). Consequently, the growing prevalence of cardiovascular disease is propelling the expansion of the transdermal skin patches market.

The growth of the transdermal skin patches market is significantly influenced by advancements in modern technologies. These technological advances are expanding the range of drugs that can be delivered transdermally, encompassing small molecule hydrophobic drugs, hydrophilic drugs, and macromolecules. The enhanced technological capabilities contribute to increased efficiency and the broader adoption of transdermal drug delivery systems (TDDS), consequently elevating the popularity and demand for TDDS. For instance, in September 2022, Corium, a biopharmaceutical company based in the United States, introduced Adlarity, a transdermal patch designed for Alzheimer's treatment. Utilizing the unique Corplex technology, Adlarity provides controlled and sustained release of donepezil, benefiting individuals with Alzheimer's-related dementia across various severity levels.

Leading companies in the transdermal skin patches market are intensifying their focus on introducing innovative products and securing approvals to establish a competitive advantage. Innovative products refer to novel or improved solutions addressing existing problems or needs, such as drugs or medical devices. In March 2022, Noven Pharmaceuticals Inc., a U.S.-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for XELSTRY (dextroamphetamine) transdermal system. This marked the first and only approved amphetamine patch for treating ADHD (Attention-Deficit or Hyperactivity Disorder). XELSTRYM, intended for use two hours before the required effect, provides sustained release for nine hours, allowing for personalized dosages based on clinical response and tolerability.

Major companies in the transdermal skin patches market are increasingly pursuing acquisitions and collaborations to strengthen and broaden their presence for market growth. These strategic mergers and acquisitions, along with collaborations, enable companies to leverage new technologies, helping them gain a competitive edge. For example, in August 2022, LTS LOHMANN Therapie-Systeme AG, a Germany-based firm specializing in medical adhesive technologies, acquired Tapemark Inc. for an undisclosed amount. This acquisition allows Tapemark's St. Paul facility to integrate into LTS's global operations network, complementing LTS's existing facilities in Germany and West Caldwell, NJ, in the U.S. Tapemark Inc. is a U.S.-based manufacturer of transdermal skin patches used for delivering medications through the skin.

In January 2022, Cumberland Pharmaceuticals Inc., a U.S.-based specialty pharmaceutical company, acquired Sancuso, a granisetron transdermal patch, from Kyowa Kirin for $13.5 million. This transaction granted Cumberland the U.S. rights to SANCUSO, enabling full control over its commercial aspects, including marketing, distribution, manufacturing, and medical support. SANCUSO, developed by Kyowa Kirin, is a transdermal patch delivering granisetron, a serotonin-3 (5-HT3) receptor antagonist, to prevent chemotherapy-induced nausea and vomiting (CINV).

Major companies operating in the transdermal skin patches market include Novartis, Hisamitsu Pharmaceutical Co., Inc, Henan Lingrui Pharmaceutical, Teva Pharmaceuticals, Luye Pharma Group Ltd, Purdue Pharma L.P., Nitto Denko Corporation, AdhexPharma, Noven Pharmaceuticals, Teikoku Pharma, Mylan Pharmaceuticals Inc, 3M Company, Acrux Ltd, Access Pharmaceuticals Inc, Rusan Pharma, Glenmark Pharmaceuticals, Cipla Ltd, Mundipharma, Dr Reddy's Laboratories, Chattem, Clarity Medical, Welcare Industries S.P. A, F.L. Medical S.r.l, Europlaz Technologies Ltd, Zentiva, Medical-Lomza Sp. z o.o., Johnson & Johnson, Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Endo Pharmaceuticals Inc.

North America was the largest region in the global transdermal skin patches market in 2024. Middle East is expected to be the fastest growing region in the transdermal skin patches market report during the forecast period. The regions covered in the transdermal skin patches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the transdermal skin patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The transdermal skin patches market consists of sales of single-layer drug-in-adhesive, multi-layer drug-in-adhesive, and vapor patch. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transdermal Skin Patches Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transdermal skin patches market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transdermal skin patches ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transdermal skin patches market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Matrix, Drug In Adhesive, Reservoir, Vapor
2) By Type: Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types
3) By Distribution Channel: Pain Relief, Nicotine Cessation,Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications
Subsegments:
1) By Matrix: Drug-in-matrix Patches; Polymer Matrix Patches
2) By Drug In Adhesive: Adhesive Matrix Patches With The Drug Incorporated In The Adhesive Layer
3) By Reservoir: Drug Reservoir Patches With A Separate Compartment For The Drug; Multi-layer Reservoir Patches
4) By Vapor: Vapor Patches That Release Active Ingredients In Vapor Form; Transdermal Patches Utilizing Vaporization Technology
Companies Mentioned: Novartis; Hisamitsu Pharmaceutical Co., Inc; Henan Lingrui Pharmaceutical; Teva Pharmaceuticals; Luye Pharma Group Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r26003

1. Executive Summary

2. Transdermal Skin Patches Market Characteristics

3. Transdermal Skin Patches Market Trends And Strategies

4. Transdermal Skin Patches Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Transdermal Skin Patches Growth Analysis And Strategic Analysis Framework

5.1. Global Transdermal Skin Patches PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Transdermal Skin Patches Market Growth Rate Analysis
5.4. Global Transdermal Skin Patches Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Transdermal Skin Patches Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Transdermal Skin Patches Total Addressable Market (TAM)

6. Transdermal Skin Patches Market Segmentation

6.1. Global Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Matrix
Drug In Adhesive
Reservoir
Vapor
6.2. Global Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Other Types
6.3. Global Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pain Relief
Nicotine Cessation
Hormone Replacement Therapy
Neurological Disorders
Cardiovascular Disorders
Other Distribution Channels
6.4. Global Transdermal Skin Patches Market, Sub-Segmentation Of Matrix, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug-In-Matrix
Monolithic Matrix
Laminated Matrix
6.5. Global Transdermal Skin Patches Market, Sub-Segmentation Of Drug In Adhesive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Layer Drug In Adhesive
Multi-Layer Drug In Adhesive
6.6. Global Transdermal Skin Patches Market, Sub-Segmentation Of Reservoir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Membrane-Controlled Reservoir
Pressure-Sensitive Reservoir
Gel Reservoir
6.7. Global Transdermal Skin Patches Market, Sub-Segmentation Of Vapor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Transdermal Vapor Patches
Self-Activated Vapor Patches
Vapor Dispensing Systems

7. Transdermal Skin Patches Market Regional And Country Analysis

7.1. Global Transdermal Skin Patches Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Transdermal Skin Patches Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transdermal Skin Patches Market

8.1. Asia-Pacific Transdermal Skin Patches Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transdermal Skin Patches Market

9.1. China Transdermal Skin Patches Market Overview
9.2. China Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transdermal Skin Patches Market

10.1. India Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transdermal Skin Patches Market

11.1. Japan Transdermal Skin Patches Market Overview
11.2. Japan Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transdermal Skin Patches Market

12.1. Australia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transdermal Skin Patches Market

13.1. Indonesia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transdermal Skin Patches Market

14.1. South Korea Transdermal Skin Patches Market Overview
14.2. South Korea Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transdermal Skin Patches Market

15.1. Western Europe Transdermal Skin Patches Market Overview
15.2. Western Europe Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transdermal Skin Patches Market

16.1. UK Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transdermal Skin Patches Market

17.1. Germany Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transdermal Skin Patches Market

18.1. France Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transdermal Skin Patches Market

19.1. Italy Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transdermal Skin Patches Market

20.1. Spain Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transdermal Skin Patches Market

21.1. Eastern Europe Transdermal Skin Patches Market Overview
21.2. Eastern Europe Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transdermal Skin Patches Market

22.1. Russia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transdermal Skin Patches Market

23.1. North America Transdermal Skin Patches Market Overview
23.2. North America Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transdermal Skin Patches Market

24.1. USA Transdermal Skin Patches Market Overview
24.2. USA Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transdermal Skin Patches Market

25.1. Canada Transdermal Skin Patches Market Overview
25.2. Canada Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transdermal Skin Patches Market

26.1. South America Transdermal Skin Patches Market Overview
26.2. South America Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transdermal Skin Patches Market

27.1. Brazil Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transdermal Skin Patches Market

28.1. Middle East Transdermal Skin Patches Market Overview
28.2. Middle East Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transdermal Skin Patches Market

29.1. Africa Transdermal Skin Patches Market Overview
29.2. Africa Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transdermal Skin Patches Market Competitive Landscape And Company Profiles

30.1. Transdermal Skin Patches Market Competitive Landscape
30.2. Transdermal Skin Patches Market Company Profiles
- 30.2.1. Novartis Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Hisamitsu Pharmaceutical Co., Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Henan Lingrui Pharmaceutical Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Teva Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Luye Pharma Group Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Transdermal Skin Patches Market Other Major And Innovative Companies

31.1. Purdue Pharma L.P.
31.2. Nitto Denko Corporation
31.3. AdhexPharma
31.4. Noven Pharmaceuticals
31.5. Teikoku Pharma
31.6. Mylan Pharmaceuticals Inc
31.7. 3M Company
31.8. Acrux Ltd
31.9. Access Pharmaceuticals Inc
31.10. Rusan Pharma
31.11. Glenmark Pharmaceuticals
31.12. Cipla Ltd
31.13. Mundipharma
31.14. Dr Reddy's Laboratories
31.15. Chattem

32. Global Transdermal Skin Patches Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transdermal Skin Patches Market

34. Recent Developments In The Transdermal Skin Patches Market

35. Transdermal Skin Patches Market High Potential Countries, Segments and Strategies

35.1 Transdermal Skin Patches Market In 2029 - Countries Offering Most New Opportunities
35.2 Transdermal Skin Patches Market In 2029 - Segments Offering Most New Opportunities
35.3 Transdermal Skin Patches Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer